Catalent Pharma Solutions has introduced its Peel-ID™ label, a new standard for clinical supply labeling designed to help reduce the risk of patients receiving the incorrect medication at clinical sites.
 
The clinical label consists of a permanent portion, and a peel-off label containing the patient kit identifier, which can be removed by site personnel and affixed elsewhere on the patient kit, inventory management, and quick retrieval. Peel-ID labels are designed and printed in-house by Catalent and are available in a variety of standard sizes and designs to fit most patient kits.
 
Catalent developed the Peel-ID label in response to some sites manually writing kit identification numbers on an unlabeled side of a package, because the label is obscured due to the way the kits are stored. The Peel-ID label addresses the risk of human error resulting from the incorrect kit being pulled from inventory due to illegible handwriting or incorrectly transposed numbers.
 
“Our clinical site liaisons recognized the potential for harm from this practice and engaged our employees to develop an innovative and practical solution,” said Esther Sadler-Williams, global director Strategic Development and Innovation at Catalent. “Peel-ID will now be our standard recommendation to customers for all patient kits packaged by Catalent, reducing risks to patient safety.”